Clinical Trials on HER2-Positive Solid Tumors

Total 19 results

  • NCT04660929
    Recruiting
    Conditions: HER2-positive, Adenocarcinoma, Bile Duct Cancer, Biliary Tract Cancer, Bladder Cancer, Breast Cancer, Breast Neoplasm, Carcinoma, Ductal, Carcinoma, Hepatocellular, Cancer, Lung Cancer, Non-Small-Cell, Carcinoma, Ovarian Epithelial, Carcinoma, Small Cell, Carcinoma, Squamous, Carcinoma, Transitional Cell, Colorectal Cancer, Esophagogastric Junction Neoplasms, Inflammatory Breast Cancer, Stomach Neoplasms, Malignant Neoplasms, Ovarian Neoplasms, Pancreatic Cancer, HER2-positive Solid Tumors, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER-2 Protein Overexpression, HER-2 Gene Amplification, Prostate Cancer, Head and Neck Cancer, Endometrial Cancer, Lung Cancer, Small Cell
  • NCT04460456
    Recruiting
    Conditions: HER2 Positive Solid Tumors
  • NCT04278144
    Recruiting
    Conditions: HER2 Positive Solid Tumors
  • NCT04727151
    Recruiting
    Conditions: HER2-Positive Solid Tumors
  • NCT03319459
    Completed
    Conditions: HER2 Positive Gastric Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, EGFR Positive Solid Tumor, Advanced Solid Tumors, HER2-positive Breast Cancer, Hepatocellular Carcinoma, Non Small Cell Lung Cancer, Renal Cell Carcinoma, Pancreatic Cancer, Melanoma
  • NCT03219268
    Active, not recruiting
    Conditions: Advanced Solid Tumors, Hematologic Neoplasms, Ovarian Cancer, HER2-positive Advanced Solid Tumors, Non Small Cell Lung Cancer, Small-cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck, Cholangiocarcinoma, Cervical Cancer, TNBC - Triple-Negative Breast Cancer
  • NCT03841110
    Recruiting
    Conditions: Advanced Solid Tumors, Lymphoma, Gastric Cancer, Colorectal Cancer, Head and Neck Cancer, Squamous Cell Carcinoma, EGFR Positive Solid Tumor, HER2-positive Breast Cancer, Hepatocellular Carcinoma, Small Cell Lung Cancer, Renal Cell Carcinoma, Pancreas Cancer, Melanoma, NSCLC, Urothelial Carcinoma, Cervical Cancer, Microsatellite Instability, Merkel Cell Carcinoma
  • NCT03251378
    Recruiting
    Conditions: Advanced Solid Tumors, Metastatic Colon Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Rectal Cancer
  • NCT04501770
    Not yet recruiting
    Conditions: HER2-Positive Solid Tumors
  • NCT01576666
    Completed
    Conditions: Dose Escalation, Safety, Preliminary Efficacy, Advanced Solid Tumors, Metastatic Breast Cancer, Advanced Pancreatic Adenocarcinoma, Metastatic Colorectal Cancer, Recurrent Glioblastoma Multiforme, Gastric Cancer, Gastroesophageal Junction Cancer, Triple Negative Metastatic Breast Cancer, Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer
  • NCT04521179
    Recruiting
    Conditions: HER2-positive Solid Tumors
  • NCT04487236
    Recruiting
    Conditions: Advanced Solid Tumors, HER2-positive Breast Cancer
  • NCT04578444
    Available
    Conditions: HER2-Positive Advanced Solid Tumors
  • NCT04257110
    Recruiting
    Conditions: Locally Advanced/Metastatic HER2 Positive Solid Tumors
  • NCT04280341
    Not yet recruiting
    Conditions: HER2-Positive Solid Tumors
  • NCT04189211
    Active, not recruiting
    Conditions: HER2-Positive Solid Tumors
  • NCT01217411
    Terminated
    Conditions: Estrogen Receptor-negative Breast Cancer, Extensive Stage Small Cell Lung Cancer, HER2-negative Breast Cancer, HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Recurrent Melanoma, Recurrent Non-small Cell Lung Cancer, Recurrent Small Cell Lung Cancer, Stage IV Breast Cancer, Stage IV Melanoma, Stage IV Non-small Cell Lung Cancer, Tumors Metastatic to Brain, Unspecified Adult Solid Tumor, Protocol Specific
  • NCT02286219
    Completed
    Conditions: Solid Tumors That Overexpress HER2 (HER2 Positive)
  • NCT01569412
    Terminated
    Conditions: Her2/Neu Positive Advanced Solid Tumors